Search results
HDFC Bank shares jump 3% to fresh high, investors eye Rs 1,900-level on MSCI boost - The Economic...
The Economic Times· 5 days agoShares of private sector lender HDFC Bank on Wednesday rallied around 3% to hit a fresh 52-week high...
Emcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription...
Livemint· 4 days agoEmcure Pharmaceuticals IPO aims to utilise funds to reduce long-term debt and focus on important...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 5 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals opens for bidding on Wednesday, July 3...
Mazagon Dock shares can rally up to Rs 6,700 before consolidating: Anand James
The Economic Times· 16 hours agoShares of PSU defence company Mazagon Dock, which ended last week 33% higher, can rally up to Rs 6,700 level before moving into a consolidation phase, says Anand James, Chief Market Strategist ...
France election: Voter turnout high, could force Emmanuel Macron to share power with far right - The...
The Economic Times· 1 day agoVoting was underway in France on Sunday in pivotal runoff elections that could hand a historic...
IREDA shares surge 7% to hit one-year high levels; how strong is this upside?
Business Today· 5 days agoShares of Indian Renewable Energy Development Agency Ltd (IREDA) surged 7.20 per cent in Wednesday's...
In Botswana, New Camps Are Bringing Guests Even Closer to Nature
Conde Nast Traveler· 9 hours agoThe boutique hotelier Atzaró has opened Atzaró Okavango Camp, which offers traditional excursions, ...
Cochin Shipyard shares zoom 10% to hit fresh record high; here's what you should do
Business Today· 4 days agoCochin Shipyard shares on Thursday soared 10 per cent to hit their all-time high value of Rs...
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 6 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 8 hours agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...